| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses | ||||||||
Research and development | ||||||||
11,955 | 9,392 | 11,374 | 8,833 | 7,889 | 6,219 | 5,386 | 5,175 | 2,893 |
General and administrative | ||||||||
4,271 | 4,179 | 3,522 | 3,307 | 2,886 | 2,222 | 1,704 | 1,634 | 1,220 |
Total operating expenses | ||||||||
16,226 | 13,571 | 14,896 | 12,140 | 10,775 | 8,441 | 7,090 | 6,809 | 4,113 |
Loss from operations | ||||||||
-16,226 | -13,571 | -14,896 | -12,140 | -10,775 | -8,441 | -7,090 | -6,809 | -4,113 |
Interest income, net | ||||||||
747 | 846 | 1,090 | 1,077 | 872 | 751 | 702 | 622 | 127 |
Loss before income taxes | ||||||||
-15,479 | -12,725 | -13,806 | -11,063 | -9,903 | -7,690 | -6,388 | -6,187 | -3,986 |
Income taxes | ||||||||
27 | 102 | - | - | - | - | - | - | - |
Net loss | ||||||||
-15,506 | -12,827 | -13,806 | -11,063 | -9,903 | -7,690 | -6,388 | -6,187 | -3,986 |
Accretion of redeemable convertible preferred stock to redemption value | ||||||||
- | 0 | 0 | 0 | 49,900 | 3,730 | 11,590 | 11,145 | 10,833 |
Net loss attributable to common stockholders | ||||||||
-15,506 | -12,827 | -13,806 | -11,063 | -59,803 | -11,420 | -17,978 | -17,332 | -14,819 |
Per share information | ||||||||
Net loss per share of common stock, basic and diluted | ||||||||
-0.65 | -0.54 | -0.58 | -0.46 | -4.85 | -16.22 | -27.25 | -27.97 | -28.90 |
Weighted average shares outstanding, basic and diluted | ||||||||
24,011 | 23,961 | 23,874 | 23,818 | 12,328 | 703 | 659 | 619 | 512 |